🔴 Harrow Health is trading 7.5% down with no clear company-specific catalyst

Harrow Health is trading 7.5% lower at $28.22, in line with healthcare-sector weakness.

• Healthcare was down 1.49% amid geopolitical and rate concerns.
• No clear company-specific announcement explained the October 9 decline; coverage highlighted clinical presentations at AAOpt and AAO, not a negative catalyst.
• Broader market coverage cited higher oil prices and Treasury yields, but described Thursday’s decline and did not specifically attribute Friday’s Harrow move.